Browsing by Author Schmidt-Erfurth, U

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2010The effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease modelMitchell, Paul (Ronald); Holz, Frank; Korobelnik, J-F; Lanzetta, P; Markabi, Sabri; Schmidli, Heinz; Schmidt-Erfurth, U; Weichselberger, Andreas; Wolf, Sebastian; Western Clinical School: Westmead Millennium InstituteThe effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease model, Investigative Ophthalmology & Visual Science, vol.51, 1,pp 405-412
2016Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW TrialsMitchell, Paul; Chong, N. Victor; Jaffe, Glenn; Katz, Todd; Lu, Chengxing; Schmidt-Erfurth, U; Simader, Christian; Staurenghi, Giovanni; Waldstein, Sebastian; Western Clinical School: Westmead Institute for Medical ResMorphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials, Ophthalmology, vol.123, 7, 2016,pp 1521-1529
2012New approaches for the treatment of diabetic macular oedema: recommendations by an expert panelMitchell, Paul (Ronald); Bandello, Francesco; Chong, N V; Cunha-Vaz, Jose Guilherme; Lang, Gabriele E.; Massin, Pascale; Porta, Massimo; Prunte, Christian; Schlingemann, Reinier O.; Schmidt-Erfurth, U; Western Clinical School: Westmead Millennium InstituteNew approaches for the treatment of diabetic macular oedema: recommendations by an expert panel, Eye, vol.26, 4, 2012,pp 485-493
2010Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trialsMitchell, Paul (Ronald); Holz, Frank; Korobelnik, J-F; Lanzetta, P; Prunte, C; Schmidt-Erfurth, U; Tano, Yasuo; Wolf, S; Western Clinical School: Westmead Millennium InstituteRanibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials, British Journal of Ophthalmology, vol.94, N/A,pp 2-13
2011The RESTORE Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular EdemaMitchell, Paul (Ronald); Bandello, Francisco; Burian, Gabriela; Gerstner, Ortrud; Lang, Gabriele E.; Massin, Pascale; Schlingemann, Reinier O.; Schmidt-Erfurth, U; Simader, Christian; Sutter, Florian K; Weichselberger, Andreas; Western Clinical School: Westmead Millennium InstituteThe RESTORE Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema, Ophthalmology, vol.118, 4, 2011,pp 615-625
2014Three-Year Outcomes of Individual Ranibizumab Treatment in Patients with Diabetic Macular Edema. The RESTORE Extension StudyMitchell, Paul; Bouazza, Abdelkader Si; Gerstner, Ortrud; Holz, Frank; Lang, Gabriele E.; Lanzetta, P; Massin, Pascale; Osborne, Aaron; Schlingemann, Reinier O.; Schmidt-Erfurth, U; Shen, Haige; Western Clinical School: Westmead Millennium InstituteThree-Year Outcomes of Individual Ranibizumab Treatment in Patients with Diabetic Macular Edema. The RESTORE Extension Study, Ophthalmology, vol.121, 5, 2014,pp 1045-1053